Skip to content
Disclosery

Boxer Capital, LLC

Follow

13F filer, CIK 1465837, San Diego, CA

Boxer Capital, LLC reported $2,037,780,820 across 68 holdings for the quarter ended 2024-09-30, in a 13F-HR filed 2024-11-14. Its ten largest share positions make up 54.88% of the portfolio.

Filed (acceptance time not in the bulk data set), ingested 13F-HR 0000895345-24-000585

Period
2024-09-30
Reported value
$2.04B
Holdings
68
Top 10 weight
54.88%
New
12
Sold out
5

Largest buys vs the previous quarter

SecurityShares changeApprox. value
TILnew+355,500$23.9M
KYMRnew+450,000$21.3M
NRIXnew+563,067$12.7M
QUREnew+2,225,000$11M
APGEnew+179,000$10.5M

Ranked by the share change valued at this quarter's implied price (value over shares in the 13F). A position sold out is valued at the previous quarter's price, its last report.

Largest sells vs the previous quarter

SecurityShares changeApprox. value
FATEreduced-3,255,000-$11.4M
ALLOexited-3,850,000-$8.97M
NKTXreduced-1,577,744-$7.13M
POSEIDA THERAPEUTICS INCreduced-2,475,000-$7.08M
AMLXexited-1,500,000-$2.85M

Ranked by the share change valued at this quarter's implied price (value over shares in the 13F). A position sold out is valued at the previous quarter's price, its last report.

Holdings, Q3 2024

Share positions as resolved from 13F-HR 0000895345-24-000585, largest first. % of portfolio is the value over $2,037,780,820, the sum of the share positions whose value is usable for ratios (method).

SecurityHistorySharesValue% of portfolioChangeLatest eventTimeline
RVMDREVOLUTION MEDICINES INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2022Q4: restricted; 2023Q1: 4,684,264 shares; 2023Q2: 4,684,264 shares; 2023Q3: 4,684,264 shares; 2023Q4: 4,279,464 shares; 2024Q1: 4,279,464 shares; 2024Q2: 4,279,464 shares; 2024Q3: 4,279,464 shares 4,279,464$194M9.52%0Timeline
TYRATYRA BIOSCIENCES INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2022Q4: restricted; 2023Q1: 6,448,359 shares; 2023Q2: 6,448,359 shares; 2023Q3: 6,448,359 shares; 2023Q4: 6,448,359 shares; 2024Q1: 6,448,359 shares; 2024Q2: 6,448,359 shares; 2024Q3: 6,448,359 shares 6,448,359$152M7.44%0Timeline
NUVLNUVALENT INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2022Q4: restricted; 2023Q1: 1,210,192 shares; 2023Q2: 1,210,192 shares; 2023Q3: 1,210,192 shares; 2023Q4: 1,120,192 shares; 2024Q1: 1,120,192 shares; 2024Q2: 1,120,192 shares; 2024Q3: 1,120,192 shares 1,120,192$115M5.62%0Timeline
ONCBEONE MEDICINES LTDQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2022Q4: restricted; 2023Q1: 500,000 shares; 2023Q2: 500,000 shares; 2023Q3: 500,000 shares; 2023Q4: 500,000 shares; 2024Q1: 500,000 shares; 2024Q2: 500,000 shares; 2024Q3: 500,000 shares 500,000$112M5.51%0Timeline
CYTKCYTOKINETICS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2022Q4: restricted; 2023Q1: 2,100,000 shares; 2023Q2: 2,100,000 shares; 2023Q3: 2,100,000 shares; 2023Q4: 2,100,000 shares; 2024Q1: 2,100,000 shares; 2024Q2: 2,100,000 shares; 2024Q3: 2,100,000 shares 2,100,000$111M5.44%0Timeline
SPRINGWORKS THERAPEUTICS INCSPRINGWORKS THERAPEUTICS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2022Q4: restricted; 2023Q1: 3,421,541 shares; 2023Q2: 3,421,541 shares; 2023Q3: 3,421,541 shares; 2023Q4: 3,421,541 shares; 2024Q1: 3,421,541 shares; 2024Q2: 3,421,541 shares; 2024Q3: 3,421,541 shares 3,421,541$110M5.38%0
MERUS N VMERUS N VQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2022Q4: restricted; 2023Q1: 1,900,000 shares; 2023Q2: 1,900,000 shares; 2023Q3: 1,900,000 shares; 2023Q4: 1,900,000 shares; 2024Q1: 1,900,000 shares; 2024Q2: 1,900,000 shares; 2024Q3: 1,900,000 shares 1,900,000$94.9M4.66%0
SRPTSAREPTA THERAPEUTICS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2022Q4: restricted; 2023Q1: 775,000 shares; 2023Q2: 600,000 shares; 2023Q3: 600,000 shares; 2023Q4: 650,000 shares; 2024Q1: 650,000 shares; 2024Q2: 650,000 shares; 2024Q3: 650,000 shares 650,000$81.2M3.98%0Timeline
RNAMAVIDITY BIOSCIENCES INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2022Q4: restricted; 2023Q1: 1,121,327 shares; 2023Q2: 1,121,327 shares; 2023Q3: 1,121,327 shares; 2023Q4: 1,121,327 shares; 2024Q1: 1,727,388 shares; 2024Q2: 1,727,388 shares; 2024Q3: 1,727,388 shares 1,727,388$79.3M3.89%0Timeline
IDYAIDEAYA BIOSCIENCES INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2022Q4: restricted; 2023Q1: 2,202,812 shares; 2023Q2: 2,202,812 shares; 2023Q3: 2,202,812 shares; 2023Q4: 2,202,812 shares; 2024Q1: 2,202,812 shares; 2024Q2: 2,202,812 shares; 2024Q3: 2,202,812 shares 2,202,812$69.8M3.42%0Timeline
TNGXTANGO THERAPEUTICS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2022Q4: restricted; 2023Q1: 7,123,642 shares; 2023Q2: 7,123,642 shares; 2023Q3: 7,123,642 shares; 2023Q4: 8,198,642 shares; 2024Q1: 8,198,642 shares; 2024Q2: 8,198,642 shares; 2024Q3: 8,198,642 shares 8,198,642$63.1M3.1%0Timeline
ARGXARGENX SEQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2022Q4: restricted; 2023Q1: not reported; 2023Q2: 75,000 shares; 2023Q3: 85,000 shares; 2023Q4: 160,000 shares; 2024Q1: 100,000 shares; 2024Q2: 100,000 shares; 2024Q3: 100,000 shares 100,000$54.2M2.66%0Timeline
APLSAPELLIS PHARMACEUTICALS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2022Q4: restricted; 2023Q1: 1,576,000 shares; 2023Q2: 1,576,000 shares; 2023Q3: 1,726,000 shares; 2023Q4: 1,726,000 shares; 2024Q1: 1,726,000 shares; 2024Q2: 1,726,000 shares; 2024Q3: 1,726,000 shares 1,726,000$49.8M2.44%0Timeline
AKROAKERO THERAPEUTICS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2022Q4: restricted; 2023Q1: 831,495 shares; 2023Q2: 1,676,733 shares; 2023Q3: 1,676,733 shares; 2023Q4: 1,676,733 shares; 2024Q1: 1,676,733 shares; 2024Q2: 1,676,733 shares; 2024Q3: 1,676,733 shares 1,676,733$48.1M2.36%0Timeline
ANABANAPTYSBIO INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2022Q4: restricted; 2023Q1: 1,300,000 shares; 2023Q2: 1,300,000 shares; 2023Q3: 1,300,000 shares; 2023Q4: 1,300,000 shares; 2024Q1: 1,300,000 shares; 2024Q2: 1,300,000 shares; 2024Q3: 1,300,000 shares 1,300,000$43.5M2.14%0Timeline
AXSMAXSOME THERAPEUTICS INC.Quarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2022Q4: restricted; 2023Q1: 400,000 shares; 2023Q2: 400,000 shares; 2023Q3: 400,000 shares; 2023Q4: 400,000 shares; 2024Q1: 400,000 shares; 2024Q2: 400,000 shares; 2024Q3: 400,000 shares 400,000$35.9M1.76%0Timeline
ITEOS THERAPEUTICS INCITEOS THERAPEUTICS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2022Q4: restricted; 2023Q1: 2,154,058 shares; 2023Q2: 2,154,058 shares; 2023Q3: 1,804,058 shares; 2023Q4: 1,804,058 shares; 2024Q1: 1,804,058 shares; 2024Q2: 2,946,915 shares; 2024Q3: 2,946,915 shares 2,946,915$30.1M1.48%0
LEGNLEGEND BIOTECH CORPQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2022Q4: restricted; 2023Q1: not reported; 2023Q2: 600,000 shares; 2023Q3: 600,000 shares; 2023Q4: 600,000 shares; 2024Q1: 600,000 shares; 2024Q2: 600,000 shares; 2024Q3: 600,000 shares 600,000$29.2M1.43%0Timeline
GERNGERON CORPQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2022Q4: restricted; 2023Q1: not reported; 2023Q2: 3,000,000 shares; 2023Q3: 3,000,000 shares; 2023Q4: 3,000,000 shares; 2024Q1: 6,000,000 shares; 2024Q2: 6,000,000 shares; 2024Q3: 6,000,000 shares 6,000,000$27.2M1.34%0Timeline
THRDTHIRD HARMONIC BIO INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2022Q4: restricted; 2023Q1: 570,417 shares; 2023Q2: 570,417 shares; 2023Q3: 520,417 shares; 2023Q4: 750,000 shares; 2024Q1: 2,000,000 shares; 2024Q2: 2,000,000 shares; 2024Q3: 2,000,000 shares 2,000,000$27.1M1.33%0Timeline
RCKTROCKET PHARMACEUTICALS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2022Q4: restricted; 2023Q1: 1,466,051 shares; 2023Q2: 1,466,051 shares; 2023Q3: 1,466,051 shares; 2023Q4: 1,466,051 shares; 2024Q1: 1,466,051 shares; 2024Q2: 1,466,051 shares; 2024Q3: 1,466,051 shares 1,466,051$27.1M1.33%0Timeline
RCUSARCUS BIOSCIENCES INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2022Q4: restricted; 2023Q1: 1,432,200 shares; 2023Q2: 1,602,200 shares; 2023Q3: 1,602,200 shares; 2023Q4: 1,602,200 shares; 2024Q1: 1,602,200 shares; 2024Q2: 1,602,200 shares; 2024Q3: 1,602,200 shares 1,602,200$24.5M1.2%0Timeline
TILINSTIL BIO INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2022Q4: restricted; 2023Q1: not reported; 2023Q2: not reported; 2023Q3: not reported; 2023Q4: not reported; 2024Q1: not reported; 2024Q2: not reported; 2024Q3: 355,500 shares 355,500$23.9M1.17%newTimeline
XENEXENON PHARMACEUTICALS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2022Q4: restricted; 2023Q1: 600,000 shares; 2023Q2: 600,000 shares; 2023Q3: 600,000 shares; 2023Q4: 600,000 shares; 2024Q1: 600,000 shares; 2024Q2: 600,000 shares; 2024Q3: 600,000 shares 600,000$23.6M1.16%0Timeline
IMVTIMMUNOVANT INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2022Q4: restricted; 2023Q1: not reported; 2023Q2: not reported; 2023Q3: 750,000 shares; 2023Q4: 1,000,000 shares; 2024Q1: 825,000 shares; 2024Q2: 825,000 shares; 2024Q3: 825,000 shares 825,000$23.5M1.15%0Timeline
KYMRKYMERA THERAPEUTICS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2022Q4: restricted; 2023Q1: not reported; 2023Q2: not reported; 2023Q3: not reported; 2023Q4: not reported; 2024Q1: not reported; 2024Q2: not reported; 2024Q3: 450,000 shares 450,000$21.3M1.05%newTimeline
SYRESPYRE THERAPEUTICS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2022Q4: restricted; 2023Q1: not reported; 2023Q2: not reported; 2023Q3: not reported; 2023Q4: 250,000 shares; 2024Q1: 250,000 shares; 2024Q2: 696,480 shares; 2024Q3: 696,480 shares 696,480$20.5M1.01%0Timeline
KURAKURA ONCOLOGY INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2022Q4: restricted; 2023Q1: not reported; 2023Q2: not reported; 2023Q3: not reported; 2023Q4: not reported; 2024Q1: 1,000,000 shares; 2024Q2: 1,000,000 shares; 2024Q3: 1,000,000 shares 1,000,000$19.5M0.96%0Timeline
KALVKALVISTA PHARMACEUTICALS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2022Q4: restricted; 2023Q1: 1,650,000 shares; 2023Q2: 1,650,000 shares; 2023Q3: 1,650,000 shares; 2023Q4: 1,650,000 shares; 2024Q1: 1,590,000 shares; 2024Q2: 1,590,000 shares; 2024Q3: 1,590,000 shares 1,590,000$18.4M0.9%0Timeline
NKTXNKARTA INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2022Q4: restricted; 2023Q1: not reported; 2023Q2: not reported; 2023Q3: not reported; 2023Q4: 1,440,000 shares; 2024Q1: 5,607,350 shares; 2024Q2: 5,607,350 shares; 2024Q3: 4,029,606 shares 4,029,606$18.2M0.89%-1,577,744Timeline
ORICORIC PHARMACEUTICALS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2022Q4: restricted; 2023Q1: 1,054,000 shares; 2023Q2: 1,732,571 shares; 2023Q3: 1,732,571 shares; 2023Q4: 1,732,571 shares; 2024Q1: 1,732,571 shares; 2024Q2: 1,732,571 shares; 2024Q3: 1,732,571 shares 1,732,571$17.8M0.87%0Timeline
GPCRSTRUCTURE THERAPEUTICS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2022Q4: restricted; 2023Q1: not reported; 2023Q2: not reported; 2023Q3: not reported; 2023Q4: 400,000 shares; 2024Q1: 400,000 shares; 2024Q2: 400,000 shares; 2024Q3: 400,000 shares 400,000$17.6M0.86%0Timeline
FATEFATE THERAPEUTICS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2022Q4: restricted; 2023Q1: 500,000 shares; 2023Q2: 500,000 shares; 2023Q3: 500,000 shares; 2023Q4: 500,000 shares; 2024Q1: 8,215,910 shares; 2024Q2: 8,215,910 shares; 2024Q3: 4,960,910 shares 4,960,910$17.4M0.85%-3,255,000Timeline
ELVNENLIVEN THERAPEUTICS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2022Q4: restricted; 2023Q1: 710,644 shares; 2023Q2: 710,644 shares; 2023Q3: 646,058 shares; 2023Q4: 646,058 shares; 2024Q1: 671,358 shares; 2024Q2: 671,358 shares; 2024Q3: 671,358 shares 671,358$17.1M0.84%0Timeline
REPLREPLIMUNE GROUP INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2022Q4: restricted; 2023Q1: not reported; 2023Q2: not reported; 2023Q3: not reported; 2023Q4: not reported; 2024Q1: not reported; 2024Q2: 1,536,341 shares; 2024Q3: 1,536,341 shares 1,536,341$16.8M0.83%0Timeline
DAWNDAY ONE BIOPHARMACEUTICALS IQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2022Q4: restricted; 2023Q1: 1,189,943 shares; 2023Q2: 1,189,943 shares; 2023Q3: 1,189,943 shares; 2023Q4: 1,189,943 shares; 2024Q1: 1,189,943 shares; 2024Q2: 1,189,943 shares; 2024Q3: 1,189,943 shares 1,189,943$16.6M0.81%0Timeline
CGEMCULLINAN THERAPEUTICS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2022Q4: restricted; 2023Q1: 1,074,082 shares; 2023Q2: 1,074,082 shares; 2023Q3: 1,074,082 shares; 2023Q4: not reported; 2024Q1: not reported; 2024Q2: 657,895 shares; 2024Q3: 907,895 shares 907,895$15.2M0.75%+250,000Timeline
ARVNARVINAS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2022Q4: restricted; 2023Q1: not reported; 2023Q2: not reported; 2023Q3: not reported; 2023Q4: 608,614 shares; 2024Q1: 608,614 shares; 2024Q2: 608,614 shares; 2024Q3: 608,614 shares 608,614$15M0.74%0Timeline
CLYMCLIMB BIO INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2022Q4: restricted; 2023Q1: not reported; 2023Q2: not reported; 2023Q3: not reported; 2023Q4: not reported; 2024Q1: not reported; 2024Q2: 2,603,190 shares; 2024Q3: 2,603,190 shares 2,603,190$13.3M0.65%0Timeline
RLAYRELAY THERAPEUTICS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2022Q4: restricted; 2023Q1: 2,169,132 shares; 2023Q2: 1,819,132 shares; 2023Q3: 1,819,132 shares; 2023Q4: 1,819,132 shares; 2024Q1: 1,819,132 shares; 2024Q2: 1,819,132 shares; 2024Q3: 1,819,132 shares 1,819,132$12.9M0.63%0Timeline
NRIXNURIX THERAPEUTICS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2022Q4: restricted; 2023Q1: 1,224,892 shares; 2023Q2: 1,224,892 shares; 2023Q3: 1,224,892 shares; 2023Q4: not reported; 2024Q1: not reported; 2024Q2: not reported; 2024Q3: 563,067 shares 563,067$12.7M0.62%newTimeline
PRTAPROTHENA CORP PLCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2022Q4: restricted; 2023Q1: 300,000 shares; 2023Q2: 300,000 shares; 2023Q3: 625,000 shares; 2023Q4: 665,000 shares; 2024Q1: 690,000 shares; 2024Q2: 690,000 shares; 2024Q3: 690,000 shares 690,000$11.5M0.57%0Timeline
QUREUNIQURE NVQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2022Q4: restricted; 2023Q1: not reported; 2023Q2: not reported; 2023Q3: not reported; 2023Q4: not reported; 2024Q1: not reported; 2024Q2: not reported; 2024Q3: 2,225,000 shares 2,225,000$11M0.54%newTimeline
APGEAPOGEE THERAPEUTICS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2022Q4: restricted; 2023Q1: not reported; 2023Q2: not reported; 2023Q3: not reported; 2023Q4: not reported; 2024Q1: not reported; 2024Q2: not reported; 2024Q3: 179,000 shares 179,000$10.5M0.52%newTimeline
OLMAOLEMA PHARMACEUTICALS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2022Q4: restricted; 2023Q1: not reported; 2023Q2: not reported; 2023Q3: not reported; 2023Q4: not reported; 2024Q1: not reported; 2024Q2: 650,000 shares; 2024Q3: 650,000 shares 650,000$7.76M0.38%0Timeline
IOVAIOVANCE BIOTHERAPEUTICS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2022Q4: restricted; 2023Q1: 3,705,133 shares; 2023Q2: 3,705,133 shares; 2023Q3: 3,705,133 shares; 2023Q4: 1,400,000 shares; 2024Q1: 750,000 shares; 2024Q2: 750,000 shares; 2024Q3: 750,000 shares 750,000$7.04M0.35%0Timeline
IPSCCENTURY THERAPEUTICS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2022Q4: restricted; 2023Q1: not reported; 2023Q2: not reported; 2023Q3: not reported; 2023Q4: not reported; 2024Q1: 1,750,000 shares; 2024Q2: 4,901,603 shares; 2024Q3: 3,900,000 shares 3,900,000$6.67M0.33%-1,001,603Timeline
JSPRJASPER THERAPEUTICS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2022Q4: restricted; 2023Q1: not reported; 2023Q2: not reported; 2023Q3: not reported; 2023Q4: not reported; 2024Q1: 350,000 shares; 2024Q2: 350,000 shares; 2024Q3: 350,000 shares 350,000$6.58M0.32%0Timeline
SANASANA BIOTECHNOLOGY INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2022Q4: restricted; 2023Q1: not reported; 2023Q2: not reported; 2023Q3: not reported; 2023Q4: not reported; 2024Q1: 1,545,000 shares; 2024Q2: 1,545,000 shares; 2024Q3: 1,545,000 shares 1,545,000$6.43M0.32%0Timeline
TERNTERNS PHARMACEUTICALS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2022Q4: restricted; 2023Q1: not reported; 2023Q2: not reported; 2023Q3: not reported; 2023Q4: not reported; 2024Q1: not reported; 2024Q2: not reported; 2024Q3: 752,000 shares 752,000$6.27M0.31%newTimeline
SRRKSCHOLAR ROCK HLDG CORPQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2022Q4: restricted; 2023Q1: not reported; 2023Q2: not reported; 2023Q3: not reported; 2023Q4: not reported; 2024Q1: not reported; 2024Q2: not reported; 2024Q3: 750,000 shares 750,000$6.01M0.29%newTimeline
POSEIDA THERAPEUTICS INCPOSEIDA THERAPEUTICS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2022Q4: restricted; 2023Q1: not reported; 2023Q2: not reported; 2023Q3: not reported; 2023Q4: not reported; 2024Q1: 4,475,000 shares; 2024Q2: 4,475,000 shares; 2024Q3: 2,000,000 shares 2,000,000$5.72M0.28%-2,475,000
SMMTSUMMIT THERAPEUTICS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2022Q4: restricted; 2023Q1: not reported; 2023Q2: not reported; 2023Q3: not reported; 2023Q4: not reported; 2024Q1: not reported; 2024Q2: not reported; 2024Q3: 250,000 shares 250,000$5.47M0.27%newTimeline
ENGNENGENE HOLDINGS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2022Q4: restricted; 2023Q1: not reported; 2023Q2: not reported; 2023Q3: not reported; 2023Q4: not reported; 2024Q1: 727,900 shares; 2024Q2: 727,900 shares; 2024Q3: 727,900 shares 727,900$4.8M0.24%0Timeline
PRLDPRELUDE THERAPEUTICS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2022Q4: restricted; 2023Q1: 699,047 shares; 2023Q2: 2,495,018 shares; 2023Q3: 2,495,018 shares; 2023Q4: 2,568,287 shares; 2024Q1: 2,568,287 shares; 2024Q2: 2,568,287 shares; 2024Q3: 1,708,187 shares 1,708,187$3.54M0.17%-860,100Timeline
BCAXBICARA THERAPEUTICS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2022Q4: restricted; 2023Q1: not reported; 2023Q2: not reported; 2023Q3: not reported; 2023Q4: not reported; 2024Q1: not reported; 2024Q2: not reported; 2024Q3: 135,000 shares 135,000$3.44M0.17%newTimeline
Mersana Therapeutics IncMersana Therapeutics IncQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2022Q4: restricted; 2023Q1: not reported; 2023Q2: 1,000,000 shares; 2023Q3: 2,000,000 shares; 2023Q4: not reported; 2024Q1: not reported; 2024Q2: not reported; 2024Q3: 1,817,000 shares 1,817,000$3.43M0.17%new
BOLDBOUNDLESS BIO INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2022Q4: restricted; 2023Q1: not reported; 2023Q2: not reported; 2023Q3: not reported; 2023Q4: not reported; 2024Q1: 711,329 shares; 2024Q2: 711,329 shares; 2024Q3: 711,329 shares 711,329$2.47M0.12%0Timeline
BDTXBLACK DIAMOND THERAPEUTICS IQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2022Q4: restricted; 2023Q1: 2,014,858 shares; 2023Q2: 2,014,858 shares; 2023Q3: 506,000 shares; 2023Q4: 506,000 shares; 2024Q1: 506,000 shares; 2024Q2: 506,000 shares; 2024Q3: 506,000 shares 506,000$2.2M0.11%0Timeline
ZNTLZENTALIS PHARMACEUTICALS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2022Q4: restricted; 2023Q1: not reported; 2023Q2: 450,000 shares; 2023Q3: 450,000 shares; 2023Q4: 450,000 shares; 2024Q1: 450,000 shares; 2024Q2: 450,000 shares; 2024Q3: 450,000 shares 450,000$1.66M0.08%0Timeline
TARAPROTARA THERAPEUTICS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2022Q4: restricted; 2023Q1: 209,227 shares; 2023Q2: 209,227 shares; 2023Q3: 209,227 shares; 2023Q4: 209,227 shares; 2024Q1: 209,227 shares; 2024Q2: 811,627 shares; 2024Q3: 811,627 shares 811,627$1.49M0.07%0Timeline
OBIOORCHESTRA BIOMED HLDGS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2022Q4: restricted; 2023Q1: 250,000 shares; 2023Q2: 250,000 shares; 2023Q3: 238,193 shares; 2023Q4: 238,193 shares; 2024Q1: 238,193 shares; 2024Q2: 238,193 shares; 2024Q3: 238,193 shares 238,193$1.22M0.06%0Timeline
ZURAZURA BIO LTDQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2022Q4: restricted; 2023Q1: not reported; 2023Q2: not reported; 2023Q3: not reported; 2023Q4: not reported; 2024Q1: not reported; 2024Q2: not reported; 2024Q3: 300,000 shares 300,000$1.22M0.06%newTimeline
BCABBIOATLA INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2022Q4: restricted; 2023Q1: 686,347 shares; 2023Q2: 686,347 shares; 2023Q3: 686,347 shares; 2023Q4: 686,347 shares; 2024Q1: 686,347 shares; 2024Q2: 686,347 shares; 2024Q3: 686,347 shares 686,347$1.21M0.06%0Timeline
MISTMILESTONE PHARMACEUTICALS INQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2022Q4: restricted; 2023Q1: 698,861 shares; 2023Q2: 698,861 shares; 2023Q3: 309,007 shares; 2023Q4: 309,007 shares; 2024Q1: 309,007 shares; 2024Q2: 309,007 shares; 2024Q3: 309,007 shares 309,007$470K0.02%0Timeline
DBV TECHNOLOGIES S ADBV TECHNOLOGIES S AQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2022Q4: restricted; 2023Q1: not reported; 2023Q2: not reported; 2023Q3: not reported; 2023Q4: not reported; 2024Q1: not reported; 2024Q2: not reported; 2024Q3: 250,000 shares 250,000$175K0.01%new
NUVATION BIO INCNUVATION BIO INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2022Q4: restricted; 2023Q1: 266,666 shares; 2023Q2: 266,666 shares; 2023Q3: 266,666 shares; 2023Q4: 266,666 shares; 2024Q1: 266,666 shares; 2024Q2: 266,666 shares; 2024Q3: 266,666 shares 266,666$26.1K<0.01%0
SRZNWSURROZEN INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2022Q4: restricted; 2023Q1: 66,666 shares; 2023Q2: 66,666 shares; 2023Q3: 66,666 shares; 2023Q4: 66,666 shares; 2024Q1: 66,666 shares; 2024Q2: 66,666 shares; 2024Q3: 66,666 shares 66,666$1.33K<0.01%0Timeline

Sold out in Q3 2024

Positions in the previous quarter's report that this quarter's report no longer lists.

SecurityShares beforeValue beforeType
ALLOALLOGENE THERAPEUTICS INC3,850,000$8.97Mshares
AMLXAMYLYX PHARMACEUTICALS INC1,500,000$2.85Mshares
ABSIABSCI CORPORATION700,000$2.16Mshares
ATARA BIOTHERAPEUTICS INC C…ATARA BIOTHERAPEUTICS INC COM NEW166,000$1.41Mshares
DBV TECHNOLOGIES S ADBV TECHNOLOGIES S A250,000$200Kshares

How Q3 2024 was built

Available 13F filings of this filer for the quarter and their roles: the base report is the latest original or restatement, NEW HOLDINGS amendments filed after it are added (method).

FilingRoleAmendmentFiledAcceptedIngested
13F-HR 0000895345-24-000585 base2024-11-14acceptance time not in the bulk data set